Agile concludes patient recruitment in contraceptive patch Phase 3 study
The company has recruited around 1500 women two months ahead of schedule at over 100 sites throughout the US. Following the completion of the the patient recruitment, Agile
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.